Press Release: Basilea Announces Agreement With Innoviva Specialty Therapeutics for the Commercialization of Antibiotic Zevtera(R) (Ceftobiprole) in the United States

新聞發佈：Basilea宣佈與Innoviva Specialty Therapeutics達成協議，在美國商業化抗生素Zevtera(R)（Ceftobiprole）

道瓊斯 · 2024/12/16 06:15

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登入免費觀看全文

登入/註冊

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

讚好

Press Release: Basilea Announces Agreement With Innoviva Specialty Therapeutics for the Commercialization of Antibiotic Zevtera(R) (Ceftobiprole) in the United States

Press Release: Basilea Announces Agreement With Innoviva Specialty Therapeutics for the Commercialization of Antibiotic Zevtera(R) (Ceftobiprole) in the United States

風險及免責聲明

聲明